Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aobo-001 (1 trial)
Enuresis (Phase 2)
Urinary Bladder, Overactive (Phase 2)
Urinary Incontinence (Phase 2)
Urinary Incontinence, Urge (Phase 2)
Trials (1 total)
Trial APIs (1 total)